🇫🇷
France · FR · FR:64721696
DILTIAZEM SANDOZ LP 200 mg, gélule à libération prolongée
ReimbursedATC C05AE03
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerSANDOZ
CountryFR (France)
ATC codeC05AE03
Dispensing—
ReimbursedYes
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 1
- cip133400927735684plaquette(s) PVC PVDC aluminium de 30 gélule(s)EUR 5.29
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "64721696",
"date_amm": "2015-04-17",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "gélule à libération prolongée",
"voies_administration": "orale",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code C05AE03.
- GBAdizem-SR 120mg capsulesLexon (UK) Ltd
- GBAdizem-SR 120mg capsulesDE Pharmaceuticals
- GBAdizem-SR 120mg capsulesMawdsley-Brooks & Company Ltd
- GBAdizem-SR 120mg capsulesWaymade Healthcare Plc
- GBAdizem-SR 120mg capsulesNapp Pharmaceuticals Ltd
- GBAdizem-SR 120mg tabletsNapp Pharmaceuticals Ltd
- GBAdizem-SR 120mg tabletsLexon (UK) Ltd
- GBAdizem-SR 180mg capsulesNapp Pharmaceuticals Ltd
Access this data programmatically
Query DILTIAZEM SANDOZ LP 200 mg, gélule à libération prolongée and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.